Antioxidant combination / Nutraceutical

4 marketed 5 in Phase 3

This page covers all Antioxidant combination / Nutraceutical drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting PPAR-γ (rosiglitazone); mitochondrial oxidative stress (alpha-lipoic acid), L-type calcium channel (diltiazem); glutathione synthesis pathway (acetylcysteine).

Targets

PPAR-γ (rosiglitazone); mitochondrial oxidative stress (alpha-lipoic acid) · L-type calcium channel (diltiazem); glutathione synthesis pathway (acetylcysteine)

Marketed (4)

Phase 3 pipeline (5)

Patent intelligence